CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer

Published:2015-07-29 Issue:28 Volume:6 Page:25356-25367
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Paret Claudia¹,Simon Petra²,Vormbrock Kirsten¹,Bender Christian¹,Kölsch Anne¹,Breitkreuz Andrea²,Yildiz Özlem²,Omokoko Tana²,Hubich-Rau Stefanie³,Hartmann Christoph¹³,Häcker Sabine¹,Wagner Meike¹³,Roldan Diana Barea³,Selmi Abderaouf¹,Türeci Özlem¹,Sahin Ugur¹²³

Affiliation:

1. TRON gGmbH, Translational Oncology at the University Medical Center, Johannes Gutenberg-University Mainz, Germany

2. BioNTech Cell & Gene Therapies, An der Goldgrube 12, Mainz, Germany

3. Experimental Oncology, Dpt. of Medicine III, Johannes Gutenberg-University, Mainz, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer;Nature Communications;2023-05-05

2. Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer;Journal of Translational Medicine;2023-03-09

3. Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy;International Journal of Molecular Sciences;2023-02-04

4. Engineered T cell therapy for viral and non-viral epithelial cancers;Cancer Cell;2023-01

5. Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors;npj Breast Cancer;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP